These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2383206)

  • 1. Antitransferrin receptor immunotoxin inhibits proliferating human retinal pigment epithelial cells.
    Jaffe GJ; Earnest K; Fulcher S; Lui GM; Houston LL
    Arch Ophthalmol; 1990 Aug; 108(8):1163-8. PubMed ID: 2383206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin.
    Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monensin enhances the cytotoxic effect of antitransferrin receptor immunotoxin on cultured RPE cells.
    Handa JT; Houston LL; Jaffe GJ
    Curr Eye Res; 1993 Jan; 12(1):45-53. PubMed ID: 8436010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferating lens epithelium with antitransferrin receptor immunotoxin.
    Goins KM; Ortiz JR; Fulcher SF; Handa JT; Jaffe GJ; Foulks GN; Cobo LM
    J Cataract Refract Surg; 1994 Sep; 20(5):513-6. PubMed ID: 7996406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts.
    Handa JT; Houston LL; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3419-28. PubMed ID: 8225877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunotoxin to inhibit proliferating human corneal endothelium.
    Fulcher S; Lui GM; Houston LL; Ramakrishnan S; Burris T; Polansky J; Alvarado J
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):755-9. PubMed ID: 3259213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
    Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J
    Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human corneal epithelium with immunotoxin 454A12-rRA.
    Fulcher SF; Foulks GN; Wilkerson M; Cobo LM; Jaffe GJ; Hatchell DL
    Cornea; 1992 Sep; 11(5):413-7. PubMed ID: 1424670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term inhibition of cellular proliferation by immunotoxins.
    Hermsen VM; Fulcher SF; Spiekerman AM; Phinizy JL; Di Tullio NW
    Arch Ophthalmol; 1990 Jul; 108(7):1009-11. PubMed ID: 2369338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of antitransferrin receptor immunotoxin from the rabbit eye.
    Handa JT; Pearson A; Jaffe GJ
    Curr Eye Res; 1996 Oct; 15(10):1039-44. PubMed ID: 8921243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of human corneal epithelial proliferation with breast carcinoma immunotoxin.
    Fulcher S; Foulks GN; Wilkerson M; Cobo LM; Houston LL; Hatchell D
    Cornea; 1993 Sep; 12(5):391-6. PubMed ID: 8306659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human subconjunctival fibroblast proliferation by immunotoxin.
    Wilkerson M; Fulcher S; Shields MB; Foulks GN; Hatchell DL; Houston LL
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2293-8. PubMed ID: 1607241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
    Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
    Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
    Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
    FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
    Laske DW; Muraszko KM; Oldfield EH; DeVroom HL; Sung C; Dedrick RL; Simon TR; Colandrea J; Copeland C; Katz D; Greenfield L; Groves ES; Houston LL; Youle RJ
    Neurosurgery; 1997 Nov; 41(5):1039-49; discussion 1049-51. PubMed ID: 9361057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
    Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V
    Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Baudouin C; Brignole F; Fredj-Reygrobellet D; Nègre F; Bayle J; Gastaud P
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2822-9. PubMed ID: 1382045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.